现代乳腺病理学报告的挑战和临床相关性:回答您的问题
Rahul Deb1, Natthawadee Laokulrath2,3, Leena Chagla4
1Department of Cellular Pathology, University Hospitals of Derby and Burton NHS Foundation Trust, Derby, UK.
综合性乳腺病理报告增强了个性化的患者护理. 本综述强调了关键的临床病理学发现,以及病理学家参与多学科团队对于最佳乳腺癌管理的重要性.
科学领域:
- 病理学 病理学 病理学
- 在瘤学瘤学.
- 组织病理学 组织病理学
背景情况:
- 乳腺病理报告已经从简单的结论演变为详细的指导方针.
- 目前的指导方针,包括来自国际癌症报告合作组织的指导方针,强调基于证据的病理学元素.
- 这些元素对于个性化和个性化的乳腺癌患者管理至关重要.
研究的目的:
- 审查乳腺病理学数据项的临床实用性.
- 通过基于病例的方法,突出显示病理学信息在各种临床场景中的相关性.
- 强调有效沟通和病理学家参与多学科团队会议的重要性.
主要方法:
- 内容基于一个关于个性化组织病理学报告的研讨会的问答会.
- 基于案例的方法被用来讨论各种乳腺病理情景.
- 讨论涵盖了特定的实体,如 florid lobular carcinoma in situ,非典型的非表皮腺,和边缘状态.
主要成果:
- 该审查涵盖了与乳腺癌管理相关的各种临床病理学主题.
- 关键领域包括新辅助药后化疗报告,非典型病变的解释和边际评估.
- 强调了特定病理学数据项的临床实用性.
结论:
- 病理学家和临床医生之间的有效沟通至关重要.
- 常规的病理学家参与乳腺多学科瘤委员会改善了患者的护理.
- 个性化组织病理学报告是乳腺瘤学个性化医学的组成部分.
更多相关视频
07:47Author Spotlight: 3D Scanning and Augmented Reality for Enhanced Cancer Surgery Communication
Published on: December 15, 2023
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
相关概念视频
Enzyme-Linked Immunosorbent Assay
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Serum Laboratory Studies, Stool Test, Breath Test
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
